{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 132,
        "end": 149
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 125,
        "end": 129
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 154,
        "end": 173
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 186,
        "end": 190
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 193,
        "end": 208
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 92,
        "end": 129
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "18852012_19",
  "text": "Studies on the eukaryotic enzymes by NMR and crystallography have facilitated understanding substrate specificities of human NAT1 ( 5-aminosalicylate and p-aminobenzoic acid ) and human NAT2 ( sulphamethazine ) ."
}
